Literature DB >> 1086832

Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

F J Crosson, J A Winkelstein, E R Moxon.   

Abstract

This study was undertaken to determine whether the terminal complement components (C3-9) are involved in the nonimmune host defense against Haemophilus influenzae type b septicemia and meningitis. Using cobra venom factor, infant rats were depleted of C3 and C5. After intranasal challenge with H. influenzae type b, the complement-depleted rats developed a greater incidence and magnitude of bacteremia and a higher mortality rate. In contrast to the effects on bacteremia, complement depletion did not directly influence either the occurrence of meningitis or bacterial multiplication within the cerebrospinal fluid. These experiments provide evidence that the complement system may be an important mechanism of natural immunity to H. influenzae type b.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086832      PMCID: PMC415467          DOI: 10.1128/iai.14.4.882-887.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Haemophilus influenzae meningitis in infant rats after intranasal inoculation.

Authors:  E R Moxon; A L Smith; D R Averill; D H Smith
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

2.  Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.

Authors:  D H Smith; G Peter; D L Ingram; A L Harding; P Anderson
Journal:  Pediatrics       Date:  1973-11       Impact factor: 7.124

3.  Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.

Authors:  S L Newman; B Waldo; R B Johnston
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

4.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

Review 5.  The complement system of man. I.

Authors:  S Ruddy; I Gigli; K F Austen
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

6.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

7.  Fatal familial Leiner's disease: a deficiency of the opsonic activity of serum complement.

Authors:  J C Jacobs; M E Miller
Journal:  Pediatrics       Date:  1972-02       Impact factor: 7.124

8.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).

Authors:  C A Alper; N Abramson; R B Johnston; J H Jandl; F S Rosen
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

9.  Bacterial meningitis. A symposium.

Authors:  D H Smith; D L Ingram; A L Smith; F Gilles; M J Bresnan
Journal:  Pediatrics       Date:  1973-10       Impact factor: 7.124

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  17 in total

1.  Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.

Authors:  S V Hetherington; C C Patrick; E J Hansen
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

2.  Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.

Authors:  S V Hetherington; C C Patrick
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae.

Authors:  G J Noel; A Brittingham; A A Granato; D M Mosser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Activation of the alternative complement pathway by Haemophilus influenzae type B.

Authors:  P H Quinn; F J Crosson; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.

Authors:  S V Hetherington
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

6.  Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b.

Authors:  J R Schreiber; C J Basker; G R Siber
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Role of complement in mouse macrophage binding of Haemophilus influenzae type b.

Authors:  G J Noel; D M Mosser; P J Edelson
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Authors:  S L Kaplan; C L Umstead; E O Mason; D C Anderson; J C Parke; R D Feigin
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

9.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Increased susceptibility of Trypanosoma lewisi infected, or decomplemented rats to Salmonella typhimurium.

Authors:  K Nielsen; J Sheppard; W Holmes; I Tizard
Journal:  Experientia       Date:  1978-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.